Resultado da Busca
14 de jan. de 2022 · Reuters. Martin Shkreli in 2017. Martin Shkreli, the former drug firm executive who ordered dramatic price hikes of a life-saving medicine, has been barred from the industry for life. In a ...
5 de abr. de 2021 · Convicted ‘Pharma Bro’ has an image problem, lawyer concedes. NEW YORK (AP) — Martin Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide “Pharma Bro” persona on social media, was convicted Friday on federal charges he deceived investors in a pair of failed hedge funds. August 4, 2017.
5 de ago. de 2017 · Um tribunal de Nova York condenou Martin Shkreli, ex-diretor de laboratório e ex-gestor de fundos de alto risco, por fraude e conspiração após ter inflado em 5.455% o preço de um medicamento ...
9 de mar. de 2018 · Martin Shkreli, the self-promoting pharmaceutical executive notorious for trolling critics online, was convicted in a securities fraud case last year unconnected to the price increase dispute.
14 de jan. de 2022 · Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a lifesaving drug, a federal judge ruled.
Martin Shkreli (* 17. März 1983 in Brooklyn, New York City; in sozialen Medien auch als „Pharma Bro“ bekannt) ist ein US-amerikanischer Hedgefondsmanager mit Schwerpunkt auf Medikamentengeschäfte. Er ist Co-Gründer des Fonds „MSMB Capital Management“ sowie Gründer und bis zum Dezember 2015 Vorsitzender der Schweizer „Turing ...
18 de mai. de 2022 · Martin Shkreli foi acusado de manipular o mercado para fazer subir os preços das ações da Retrophin, empresa farmacêutica fundada por ele em 2011. — Foto: Bloomberg Antigo executivo da indústria farmacêutica conhecido como "Pharma Bro", Martin Shkreli saiu da prisão nos Estados Unidos, tendo cumprido cinco dos sete anos a que foi sentenciado, segundo a Business Insider.
